Cantor's Dentice sees personalized medicine spurring M&A

thedealvideo
  • 12 years ago
The co-head of Cantor Fitzgerald's healthcare investment banking unit predicts that personalized medicine companies will become hot M&A targets for drugmakers and other life sciences companies.

Recommended

2:20
I
Up next
The Benefits of Personalized Medicine
Ac Health
1:43
Precision medicine in colorectal cancer to provide personalized treatment
Arirang News
1:15
Deals in Oncology Personalized Medicine Industry -- Worldwide Analysis
RenubResearch
3:31
The Power of Precision Medicine, Personalized Care & A Brave Kid: Beorn’s Story | Dell
3BL Media
1:25
Personalized Medicine Diagnostics (http://www.renub.com/report/life-science/)
RenubResearch
4:25
How Close Are We to "Personalized" Medicines?
Big Think

Featured channels

More from
Billie Eilish
More from
TIME
More from
SportsGrid
More from
Billboard
More from
Travel and Leisure
More from
TMZ